www.pharmaceuticalprocessingworld.com Open in urlscan Pro
141.193.213.10  Public Scan

Form analysis
1 forms found in the DOM

GET https://www.pharmaceuticalprocessingworld.com/

<form class="search-form" method="get" action="https://www.pharmaceuticalprocessingworld.com/" role="search"><input class="search-form-input" type="search" name="s" id="searchform-1" placeholder="Search this website"><input class="search-form-submit"
    type="submit" value="GO">
  <meta content="https://www.pharmaceuticalprocessingworld.com/?s={s}">
</form>

Text Content

PHARMACEUTICAL PROCESSING WORLD



 * Home
 * Regulatory
   * Recalls
 * Pharmaceutical Processing
 * Facility
 * Supply Chain
 * Equipment and Materials
 * Contract Manufacturing
 * 



LONZA BUYS GENENTECH MANUFACTURING PLANT FROM ROCHE FOR $1.2B

NOVARTIS BEGINS $256M SINGAPORE EXPANSION

COULD PHARMA PRODUCTION SOMEDAY MOVE TO SPACE?

GENENTECH, SANOFI BOTH PLAN TO LAY OFF HUNDREDS AROUND SAN FRANCISCO

FUJIFILM INVESTS $1.2 BILLION IN NORTH CAROLINA BIOPHARMACEUTICAL MANUFACTURING
FACILITY

NOVO NORDISK AND GINKGO BIOWORKS EXTEND MANUFACTURING, R&D PARTNERSHIP

CARDINAL HEALTH STARTS CONSTRUCTION ON NEW PHARMACEUTICAL DISTRIBUTION CENTER

ASTELLAS BREAKS GROUND ON €330M MANUFACTURING FACILITY IN IRELAND

REPORT: JAPAN HEALTH AUTHORITIES INVESTIGATE KOBAYASHI PHARMACEUTICAL FACTORY
AFTER FIVE DEATHS

LONZA BUYS GENENTECH MANUFACTURING PLANT FROM ROCHE FOR $1.2B

NOVARTIS BEGINS $256M SINGAPORE EXPANSION

COULD PHARMA PRODUCTION SOMEDAY MOVE TO SPACE?

GENENTECH, SANOFI BOTH PLAN TO LAY OFF HUNDREDS AROUND SAN FRANCISCO

FUJIFILM INVESTS $1.2 BILLION IN NORTH CAROLINA BIOPHARMACEUTICAL MANUFACTURING
FACILITY

NOVO NORDISK AND GINKGO BIOWORKS EXTEND MANUFACTURING, R&D PARTNERSHIP

TODAY ON PHARMACEUTICAL PROCESSING

By Danielle Kirsh | April 18, 2024


FERRING PHARMACEUTICALS, SK PHARMTECO ENTER COMMERCIAL GENE THERAPY
MANUFACTURING DEAL

Ferring Pharmaceuticals and SK pharmteco today announced an agreement to scale
up commercial manufacturing capacity for Ferring’s drug substance intravesical
non-replicating gene therapy, Adstiladrin. The deal will help ensure the
long-term future supply of gene therapy. Following the technology transfer, SK
pharmteco will be qualified as another source for manufacturing, testing and
release of the…


By Danielle Kirsh | April 18, 2024


TRILINK BIOTECHNOLOGIES OPENS NEW MRNA MANUFACTURING FACILITY

TriLink BioTechnologies today announced it opened its new cGMP mRNA
manufacturing facility. The new 32,000 sq. ft. facility, based in San Diego, is
specifically designed for mRNA manufacturing. Using the company’s mRNA
manufacturing capabilities, it will support late-phase drug developers from
Phase 2 to commercialization. TriLink said the opening is expected to help
advance the…


By Danielle Kirsh | April 17, 2024


JAVELIN BIOTECH APPOINTS JACQUES BANCHEREAU AS CHIEF SCIENTIFIC OFFICER

Javelin Biotech today announced it appointed Jacques Banchereau as chief
scientific officer, effective immediately. Banchereau has more than 35 years of
experience in academic and industrial research. He has held roles such as
Professor and Director of Immunological Sciences at the Jackson Laboratory for
Genomic Medicine, Chief Scientific Officer at Hoffman-La Roche, CSO at Immunai,…


Read All Articles >

SPONSORED CONTENT SEE MORE >

A new way to access scientific papers?
Losing university access doesn’t mean losing access to articles anymore By
DeepDyve Digital Library Team Many researchers are surprised to…
Anti-idiotype Antibodies: A Powerful Weapon for PK/ADA Assays
By Sino Biological Therapeutic monoclonal antibodies have emerged as the
fastest-growing class of therapeutics since the mid-1980s from the increasing…
Noble expands its services for its clients into Human Factors
Human Factors + (HF+) is a natural extension of Noble’s deep understanding of
the patient experience relative to self-administering drug…
Personalized medicine: advanced technology is saving lives
The concept of a “batch size one” in pharmaceutical manufacturing is closer than
ever. There are companies advancing cell therapies…
MES for Flexible, Paperless Pharmaceutical Production
All companies in the pharmaceutical industry are under pressure for time,
quality, compliance, and innovation. These pressures create imperatives to…
Pave the way to high productivity with continuous manufacturing for pharma
Continuous manufacturing in the pharmaceutical industry is increasing as more
manufacturers realize the benefits of the technology. But no two…
Revolutionizing Pharma Sustainability: Grundfos Solutions for Optimizing
Efficiency
This white paper highlights the pressing need for sustainability in the
pharmaceutical industry, where energy-intensive processes contribute
significantly to environmental…
The Evolution of Heat Sealing
by Charles H. Trillich / Co-Founder Packworld USA Heat sealing technology has
evolved over many decades to reduce cost and…
Difficult transmembrane protein targets for therapeutic antibodies
What is the current landscape of antibodies targeting membrane proteins? As of
June 2022, 162 antibodies had been approved for…
Validatable Band Sealers for Medical Pouches
By Lynn Miranda, Sales Manager for All Packaging Machinery Corp, Ronkonkoma, NY.
The customer’s level of confidence and trust is…
Raumedic: A Trusted Partner in Serving the Pharmaceutical Industry with the Gold
Standard in Silicone Tubing
Raumedic is a trusted partner in the international medical technology and
pharmaceutical industry. The medical division of the global corporation…
A new way to access scientific papers?
Losing university access doesn’t mean losing access to articles anymore By
DeepDyve Digital Library Team Many researchers are surprised to…
Anti-idiotype Antibodies: A Powerful Weapon for PK/ADA Assays
By Sino Biological Therapeutic monoclonal antibodies have emerged as the
fastest-growing class of therapeutics since the mid-1980s from the increasing…
Noble expands its services for its clients into Human Factors
Human Factors + (HF+) is a natural extension of Noble’s deep understanding of
the patient experience relative to self-administering drug…
Personalized medicine: advanced technology is saving lives
The concept of a “batch size one” in pharmaceutical manufacturing is closer than
ever. There are companies advancing cell therapies…
MES for Flexible, Paperless Pharmaceutical Production
All companies in the pharmaceutical industry are under pressure for time,
quality, compliance, and innovation. These pressures create imperatives to…
Pave the way to high productivity with continuous manufacturing for pharma
Continuous manufacturing in the pharmaceutical industry is increasing as more
manufacturers realize the benefits of the technology. But no two…

REGULATORY SEE MORE >

FDA APPROVES MERCK’S WINREVAIR TO TREAT PULMONARY ARTERIAL HYPERTENSION

Merck recently won FDA approval for its sotatercept-csrk Winrevair for treating
adults with pulmonary arterial hypertension. The drug was approved to increase
exercise capacity and reduce the risk of clinical worsening events, according to
the Rahway, N.J.-based company. It previously received FDA breakthrough
designation and is the first FDA-approved action signaling inhibitor therapy for
pulmonary…

REPORT: JAPAN HEALTH AUTHORITIES INVESTIGATE KOBAYASHI PHARMACEUTICAL FACTORY
AFTER FIVE DEATHS

EICOS SCIENCES’ FDA-APPROVED AURLUMYN PROMISES TO DRASTICALLY REDUCE FROSTBITE
AMPUTATIONS

ABBVIE LAUNCHES PRODUODOPA IN THE EU TO TREAT PARKINSON’S

FDA TAKING HANDS-OFF APPROACH IN ENFORCING MEDICATION PROMOTION ON TIKTOK

LEARN HOW TO RAPIDLY DEVELOP SMART AND SUSTAINABLE ENGINEERING AND PRODUCTION
PROCESSES SEE MORE >

PERSONALIZED MEDICINE: ADVANCED TECHNOLOGY IS SAVING LIVES

The concept of a “batch size one” in pharmaceutical manufacturing is closer than
ever. There are companies advancing cell therapies in which body cells are used
to heal or support the individual patient. These cells are manipulated or edited
to change certain biological characteristics before being transferred to the
patient. Personalized medicine is truly about…

MES FOR FLEXIBLE, PAPERLESS PHARMACEUTICAL PRODUCTION

PAVE THE WAY TO HIGH PRODUCTIVITY WITH CONTINUOUS MANUFACTURING FOR PHARMA

FACILITY SEE MORE >

SEN-JAM PHARMA, KVK-TECH PARTNERING FOR MANUFACTURING AND FORMULATION FOR
ANTI-INFLAMMATORY INJECTABLES

Sen-Jam Pharmaceutical this week announced it is partnering with specialty
pharmaceutical manufacturer KVK-Tech for formulation and chemistry,
manufacturing and controls for anti-inflammatory injectables. The partnership is
the third development, manufacturing, distribution and license agreement the
pair have signed. The new partnership will further advance Sen-Jam’s first
injectable anti-inflammatory therapeutic, SJP-100. Sen-Jam is developing an
immunomodulator…

FUJIFILM INVESTS $1.2 BILLION IN NORTH CAROLINA BIOPHARMACEUTICAL MANUFACTURING
FACILITY

KINTARA THERAPEUTICS, TUHURA TO MERGE IN ALL-STOCK TRANSACTION

SCHOTT PHARMA COMMITS $371 MILLION TO NEW U.S. MANUFACTURING FACILITY FOR GLP-1,
MRNA THERAPIES

PFIZER GIVES UP ON WASHINGTON STATE MANUFACTURING PLANT PROJECT

SUPPLY CHAIN SEE MORE >

TELIX PHARMACEUTICALS TO BUY ARTMS AND ITS ISOTOPE PRODUCTION PLATFORM

Telix Pharmaceuticals announced that it agreed to acquire radioisotope
production technology firm ARTMS Inc. ARTMS also brings with it an advanced
cyclotron-based isotope production platform and manufacturing plant. It has a
stockpile of ultra-pure rare metals required for consumable target production,
too, according to a news release. The company specializes in the physics,
chemistry and…

BD LAYS OFF 100 AT BIOTECH REAGENT PLANT IN CALIFORNIA

BORA PHARMACEUTICALS IS BUYING GENERICS MAKER UPSHER-SMITH

NOVARTIS OPENS NEW RADIOLIGAND THERAPY MANUFACTURING FACILITY IN INDIANAPOLIS

BIDEN’S SUPPLY CHAIN PLANS INCLUDE MADE-IN-AMERICA MEDICINES

RECALLS SEE MORE >

REPORT: JAPAN HEALTH AUTHORITIES INVESTIGATE KOBAYASHI PHARMACEUTICAL FACTORY
AFTER FIVE DEATHS

Japanese health authorities searched a Kobayashi Pharmaceutical factory in Japan
following reports of five deaths related to dietary supplements, Reuters
reports. The plant inspection in western Japan is the second in recent days as
health authorities inspected the company’s Osaka facility. In addition to the
five reported deaths, there have been more than 100 hospitalizations…

PBMS INCREASINGLY UNDER FIRE IN DRUG-PRICING BATTLE

TIMELINE: NAVIGATING JOHNSON & JOHNSON’S TALC LAWSUITS AND THEIR STOCK
PERFORMANCE IMPACT

5 CORE TRENDS IN DRUG RECALLS: AN ANALYSIS OF 2022 AND Q1 2023

PRISM.SCIENCE DEBUTS NEW ADVERSE-EVENT MONITORING TOOL

EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical
Processing.
GET THE ENEWSLETTER


DEVICETALKS TUESDAYS



MEDTECH 100 INDEX

Market Summary > Current Price
$75.70
19 april 2024 om 22:00 CEST

The MedTech 100 is a financial index calculated using the BIG100 companies
covered in Medical Design and Outsourcing.
Click for Index Details >>


Connect with Pharmaceutical Processing World
Pharmaceutical Processing World
 * Subscribe to our E-Newsletter
 * Contact Us
 * About Us
 * R&D World
 * Drug Delivery Business News
 * Drug Discovery & Development
 * DeviceTalks
 * MassDevice
 * Medical Design & Outsourcing
 * MEDICAL TUBING + EXTRUSION
 * Medical Design Sourcing
 * Medtech100 Index
 * R&D 100 Awards

Copyright © 2024 WTWH Media LLC. All Rights Reserved. The material on this site
may not be reproduced, distributed, transmitted, cached or otherwise used,
except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us


SEARCH PHARMACEUTICAL PROCESSING WORLD





 * Home
 * Regulatory
   * Recalls
 * Pharmaceutical Processing
 * Facility
 * Supply Chain
 * Equipment and Materials
 * Contract Manufacturing

×
We Value Your Privacy
Settings
NextRoll, Inc. ("NextRoll") and our 18 advertising partners use cookies and
similar technologies on this site and use personal data (e.g., your IP address).
If you consent, the cookies, device identifiers, or other information can be
stored or accessed on your device for the purposes described below. You can
click "Allow All" or "Decline All" or click Settings above to customise your
consent regarding the purposes and features for which your personal data will be
processed and/or the partners with whom you will share personal data.
NextRoll and our advertising partners process personal data to: ● Store and/or
access information on a device; ● Create a personalised content profile; ●
Select personalised content; ● Personalised advertising, advertising
measurement, audience research and services development; ● Services development.
For some of the purposes above, our advertising partners: ● Use precise
geolocation data. Some of our partners rely on their legitimate business
interests to process personal data. View our advertising partners if you wish to
provide or deny consent for specific partners, review the purposes each partner
believes they have a legitimate interest for, and object to such processing.
If you select Decline All, you will still be able to view content on this site
and you will still receive advertising, but the advertising will not be tailored
for you. You may change your setting whenever you see the Manage consent
preferences on this site.
Decline All
Allow All
Manage consent preferences